Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Clin Rheumatol ; 42(5): 1469-1477, 2023 May.
Article in English | MEDLINE | ID: mdl-36637635

ABSTRACT

Takayasu arteritis (TA) is an uncommon chronic granulomatous large-vessel vasculitis affecting the aorta and its branches. Pyoderma gangrenosum (PG) is a chronic neutrophilic dermatosis characterized by rapidly developing painful ulcers. The association of PG with TA is relatively uncommon. We report a case of a 22-year-old lady with a history of recurrent pyoderma lesions for 4 months following which she developed right upper limb claudication. She underwent contrast-enhanced magnetic resonance angiography of the aorta and its branches and was initially diagnosed with type IIb TA. She was put on prednisolone and methotrexate but had a major relapse with new-onset lower limb claudication despite an appropriate course of immunosuppression. She was planned for tocilizumab infusion 8 mg/kg intravenous every 4 weeks. Following the first dose of tocilizumab, her vascular symptoms improved but she had a flare of PG. This was followed by another flare after the second dose. She was switched to tofacitinib which led to sustained remission of her TA activity and healing of her skin lesions, and the prednisolone dose could be reduced to 5 mg daily over the next 1 year. Various immunosuppressives were used to date for treating PG in TA. However, tofacitinib is being reported for the first time in literature for treating PG and controlling TA activity. The paradoxical flare of PG with tocilizumab is quite uncommon and is also reported in our case with literature review.


Subject(s)
Pyoderma Gangrenosum , Takayasu Arteritis , Humans , Female , Young Adult , Adult , Pyoderma Gangrenosum/complications , Pyoderma Gangrenosum/drug therapy , Pyoderma Gangrenosum/pathology , Takayasu Arteritis/complications , Takayasu Arteritis/drug therapy , Takayasu Arteritis/diagnosis , Immunosuppressive Agents/therapeutic use , Methotrexate/therapeutic use , Prednisolone/therapeutic use
3.
Lupus ; 31(9): 1132-1137, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35713230

ABSTRACT

Introduction: Macrophage Activation Syndrome (MAS) is a rare but potentially fatal complication in rheumatic diseases. Here, we report the case of a 14-year-old girl with MAS as the primary manifestation of Systemic Lupus Erythematosus (SLE). She had three episodes of MAS during the course of her treatment. This case is unique as recurrent MAS in pediatric SLE is rare.Methods: Demographic, clinical, laboratory features and outcomes of our patient was noted. We also reviewed the two reported cases of recurrent MAS in pediatric SLE. Literature review was performed on PubMed search forum. Search items included Macrophage activation syndrome, pediatric systemic lupus erythematosus, recurrent MAS.Conclusion: The diagnosis and management of MAS are challenging as it can simulate an infectious complication or can be the exacerbation of the underlying disease. Early detection and prompt treatment can reduce morbidity in these patients.


Subject(s)
Lupus Erythematosus, Systemic , Macrophage Activation Syndrome , Rheumatic Diseases , Adolescent , Female , Humans , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/drug therapy , Macrophage Activation Syndrome/diagnosis , Macrophage Activation Syndrome/etiology , Rheumatic Diseases/complications
4.
BMC Rheumatol ; 4: 24, 2020.
Article in English | MEDLINE | ID: mdl-32518895

ABSTRACT

BACKGROUND: Our study aimed to compare efficacy and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Limited) versus reference adalimumab (Humira®, Abbvie Inc.) in Indian patients with active rheumatoid arthritis (RA) concomitant on methotrexate (MTX) therapy. METHODS: Patients (n = 168) were randomized (2:1) to receive either test or reference product for 24 weeks with concomitant MTX. Proportion of patients achieving American College of Rheumatology 20 (ACR20) criteria at week 12 was the primary endpoint. Changes in Disease Activity Score of 28 joints-C-reactive protein (DAS28-CRP), Health Assessment Questionnaire-Disability Index (HAQ-DI), and patients achieving ACR20 at week 24, ACR50/70 at weeks 12 and 24 were secondary endpoints. RESULTS: Patients achieving ACR20 responses with test (96.43%) were similar to reference (96.43%) in intention-to-treat (ITT) analysis at week 12. Proportional difference (PD) between groups (PD [95% CI] 0.0 [- 6.0, 6.0], p = 1.000) for ACR20 at week 12 for ITT analysis showed lower limit of the two-sided 95% CI was above the pre-specified noninferiority margin of - 15%. Similar trend in PP analysis (PD [95% CI] 0.0 [- 0.03, 0.07], p = 1.000), confirmed therapeutic equivalence. No significant difference was noted between arms for patients attaining ACR20 at week 24 and ACR50/70 at weeks 12 and 24 (all p > 0.05). DAS28-CRP and HAQ-DI were similar between groups. Total of 54 patients reported 88 AEs during the study. Out of these, 60 AEs were reported in 34 patients with Hetero-Adalimumab and 28 AEs were reported in 20 patients with Reference-Adalimumab. Total two patients, one in each group reported two serious adverse events (Sinusitis and Viral infection) during the study and resolved completely. No deaths and no life threatening AEs were reported. CONCLUSION: Results demonstrated Hetero's adalimumab is as effective and well tolerated as reference adalimumab in patients with active RA concomitantly on MTX therapy. TRIAL REGISTRATION: CTRI/2016/04/006884, Registered on 28/04/2016.

5.
J Emerg Med ; 56(5): 512-518, 2019 May.
Article in English | MEDLINE | ID: mdl-30879855

ABSTRACT

BACKGROUND: The nature and profile of different modes of poisoning vary significantly in different parts of India. The assessment of the magnitude of suicidal poisoning is an area of paramount importance not only for appropriate management but also for raising social awareness and framing government policies for the prevention of same. OBJECTIVES: We aimed to determine the pattern of poisoning, the sociodemographic profile of patients who poison themselves, and the in-hospital outcome of self-poisoned patients over a 1-year period. METHODS: This was a cross-sectional observational study conducted between May 2015 and April 2016 that included 492 patients >12 years of age who were admitted to our hospital after consuming poison with the intention of deliberate self-harm. Relevant history with respect to the nature and amount of poison ingested were taken and recorded, and the patients' sociodemographic profiles and outcome (as either discharge or death) were noted. RESULTS: Most of the patients were 13-28 years of age (69%). Males (n = 293 [59.55%]) predominated over females and the majority were farmers (n = 193 [39.23%]). Rural cases (n = 373 [75.81%]) outnumbered urban cases. The major causes of deliberate self-harm attempts were impulsive actions (n = 442 [89.84%]). Pesticides (n = 393 [79.88%]) were the most commonly consumed poison. The overall mortality rate was 12%, with paraquat (94.74%) topping the list of fatal substances. CONCLUSION: Young adults and males constitute majority of the population in this study. Agricultural poisons made up the bulk of the cases, mostly taken by rural population. Paraquat, an herbicide banned in several countries, had the highest mortality rate in this study.


Subject(s)
Inpatients/psychology , Poisoning/psychology , Suicide/statistics & numerical data , Adolescent , Adult , Carboxylic Ester Hydrolases/poisoning , Cross-Sectional Studies , Female , Humans , India/epidemiology , Inpatients/statistics & numerical data , Male , Organophosphate Poisoning/epidemiology , Poisoning/epidemiology , Pyrethrins/poisoning , Suicide/psychology , Tertiary Care Centers/organization & administration , Tertiary Care Centers/statistics & numerical data
6.
J Clin Orthop Trauma ; 5(4): 199-202, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25983498

ABSTRACT

INTRODUCTION: Osteoarthritis and Osteoporosis are highly prevalent disease, so is hypovitaminosis D. We tried to find out prevalence of osteoporosis and hypovitaminosis D in patients suffering from primary knee Osteoarthritis. We also compared the prevalence of oseotoporosis between general population and patients of primary osteoarthritis. METHODS: Patients suffering from primary knee OA were taken from Rheumatology OPD of Medical College Hospital and SSKM Hospital Kolkata, India. For each patient age and sex matched friend or relative of same locality was taken in the study as controls. Hospital staffs that come from different part of state was taken in the study as controls. The control population was the representative of general population. RESULTS: Total number of participants in this study was 206. Out of which there were 98 cases and 108 controls. BMD status correlates significantly with Primary OA. Serum Vitamin D3 status correlates significantly with Osteoarthritis. Age of the patients correlated significantly with both BMD Status and Knee OA but not with the vVitamin D level. There were significant correlation between the Serum Vitamin D3 status and BMD of the subjects. CONCLUSION: Osteoporosis is prevalent both in general population and patients suffering from Knee Osteoarthritis and may increase the disability. The matter is complicated by the fact hypovitaminosis D is also prevalent in the population and positively correlated with both Osteoporosis and osteoarthrosis, though we cannot comment on further pathogenesis because of cross sectional design of the study.

8.
J Infect Dev Ctries ; 5(7): 550-2, 2011 Jul 27.
Article in English | MEDLINE | ID: mdl-21795825

ABSTRACT

Membranous glomerulonephritis is rarely associated with tuberculosis infection. We report a case of a 24-year-old female with tuberculous peritonitis associated with membranous glomerulonephritis causing subnephrotic range proteinuria. Histological examination confirmed both diagnoses. The patient showed improvement with anti-tubercular drugs over six months of follow-up.


Subject(s)
Glomerulonephritis, Membranous/complications , Glomerulonephritis, Membranous/diagnosis , Peritonitis, Tuberculous/complications , Peritonitis, Tuberculous/diagnosis , Antitubercular Agents/therapeutic use , Female , Glomerulonephritis, Membranous/drug therapy , Glomerulonephritis, Membranous/pathology , Histocytochemistry , Humans , Microscopy , Mycobacterium tuberculosis/isolation & purification , Peritonitis, Tuberculous/drug therapy , Peritonitis, Tuberculous/pathology , Proteinuria/diagnosis , Young Adult
10.
Suicide Life Threat Behav ; 38(5): 576-91, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19014309

ABSTRACT

The results of a systematic literature review that investigated suicide intent are presented. Of the 44 relevant articles identified, 17 investigated the relationships between various suicide risk factors and suicide intent and 25 publications investigated the relationships between suicide intent and various suicide outcomes. Despite recent advancements in the definition and nomological validity of suicide intent, a high degree of variability in the empirical measurement and analysis of suicide intent was found. Such variability limits future research related to measuring suicidal risk and outcomes, reporting suicide intent, or the meaningful comparison of diagnostic approaches or treatments across multiple studies.


Subject(s)
Intention , Suicide, Attempted/psychology , Humans
11.
IEEE Trans Inf Technol Biomed ; 9(2): 162-8, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16138532

ABSTRACT

Although knowledge management (KM) tools are well established in technical support organizations, health-care organizations have only recently become aware of their benefits. This research investigates whether health care should adopt the same tools taking into account the different KM requirements in the two industries. This study analyzes narratives from key personnel in a technical support organization and a health-care organization to understand and compare their KM process components and facilitating information technology. The empirical data reveal that health care needs a personalization approach to KM focusing on new problem identification using interactive knowledge webs, while technical support relies on a codification approach for problem resolution using interpretive knowledge and a chain structure.


Subject(s)
Delivery of Health Care/organization & administration , Information Management , Diffusion of Innovation
SELECTION OF CITATIONS
SEARCH DETAIL
...